- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
? In conclusion, IAD is currently widely offered to patients with PCa in various clinical settings, and its status should no longer be regarded as investigational (LE: 2). 存在什么问题? ? 是否回加速疾病进展? ? PSA 是否是合适的判断指标? ? 缺乏大样本的随机对照研究 间歇性内分泌治疗临床研究 ? Overall, eight randomised trials are underway, only some of which have published findings. Most of the trials included a mixed patient population, i.e. both locally advanced and metastatic disease. Only three trials included only metastatic patients, and two trials only relapsing patients. The two largest trials each contained more than 1,300 patients, with one trial focused only on metastatic patients (SWOG 9346) and the other on relapsing patients after radiotherapy (SWOG JPR7) 间歇雄激素去除与持续雄激素去除治疗激素敏感性 转移性前列腺癌 : 国际 III 期临床研究 SWOG 9346 (INT-0162) 结果 Hussain M, Tangen CM, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Akdas A, Small EJ, Dawson NA, Donnelly BJ, Venner P, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Vogelzang NJ, Thompson Jr, IM Univ. of Michigan, Ann Arbor, MI; SWOG Statistical Center, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA; University of Colorado Health Science Center, Aurora, CO; University of Wisconsin Carbone Cancer Center, Madison, WI; St. James University Hopsital, Leeds, UK; Marmara University, Istanbul, Turkey; University of California, San Francisco, San Francisco, CA; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington, DC; Prostate Cancer Institute, Calgary, Alberta, Canada, Calgary, AB; Cross Cancer Institute, Edmonton, AB; Karmanos Cancer Institute, Wayne State University, Detroit, MI; Urology of Virginia, Norfolk, VA; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; Levine Cancer Institute, Carolinas HealthCare System, Charlotte NC; US Oncology Research, LLC, McKesson Specialty Health, The Woodlands, TX, and Comprehensive Cancer Centers of Neva
文档评论(0)